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1, INTRODUCTION 
Several rlinical and experimelieal studies have firmly 
established acorrelation between elevated levels of low 
density lipoprotein (LDL) and the onset of 
atheroxclcrosis (reviewed in [IJ]). There arc fewer 
native LDL receptors in macrophagcs; conscqucntly, 
LDL undergoes little degradation by these cells [1,2]. 
Nowcver, the LDL that has been modified by trace 
metals [3,4], lipoxygcnase [S] artd endothelial cells [6,7] 
is rapidly degraded in macrophagcs by an alternate 
scavenger receptor which ultimately leads to the forma- 
tion of ‘foam cells’ [2]. Results from studies using an- 
tioxidants have shown a definite involvement of free 
radicals during the conversion of the ‘native’ LDL to 
the more athcrogenic ‘oxidatively-modified’ LDL 
W3,91. 
Recently, we have shown that an LDL-associated OL- 
tocopheroxyl radical is formed during oxidation of 
LDL by Cu2+ and lipoxygenase [lOl. This study has 
also shown that the LDL-lipid-derived radicals are 
responsible for formation of the a-tocopheroxyl 
radical. The study also leads to the formulation of the 
following hypothesis: ‘If oxidative modification of 
LDL is mediated by lipid-derived radicals, then trapp- 
ing them with the lipophilic spin trap, cr-phenyl N-tert- 
butylnitrone (PBN), should decrease the modification 
of the LDL and the subsequent degradation by 
macrophages’ . 
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The purpose of the study reported in this paper was 
(i) to investigate the effect of PBN on the oxidation of 
LDL. by Cu’ + and the endothelial cells, and (ii) to 
demonstrate directly the formation of free radicals in 
LDL particles by electron spin resonance (ESR). 
2. EXPERIMENTAL 
PBN was obtained from Sigma and used as rcccivcd, All other 
chemicals were of reagent grade and used as received. Agarose clcc. 
trophoresis gels wcrc from Corning Medical Co. (Palo Alto, CA). 
LDL (Q = 1.019-1,063) was isolated by ultraccntrifugation from 
pooled normal human plasma collcctcd in EDTA (I mg/ml) [3], 
EDTA was present throughout the isolation and dialysis IO prevent 
oxidation of LDL, All lipoprotein samples were dialyzed against 
phosphate-buffered saline (PBS) containing I mg/ml EDTA at 4°C. 
Protein was dctcrmincd by the Lowry method using bovine serum 
albumin as a standard. 
2.3. ESR smnpI~’ prepworion 
A typical incubation contained 6-8 mg/ml of LDL protein, Cuat 
500 PM and the spin trap (PBN) in a 0.25 ml PBS buffer (pM 7.8, 10 
mM NaCI) saturated with air. PBN (100 mM) was dissolved in the 
buffer. After incubating for 16 h, the incubation was extracted with 
750 ~1 of chloroform:methanol (2:l) mixture, evaporated to dryness 
over NZ gas, dissolved in 200 ~1 of ethanol and :aken up in an aqueous 
flat cell for ESR analysis. ESR measurements at ambient te.mperaturc 
were carried out in a Varian E-109 spectrometer operating at 9.5 GWr 
and employing 100 kI-iz field modulation. 
2.4. Synthesis of PBN-ulkyl odducrs 
PBN-pentyl, -decyl and -tetradecyl adducts were prepared from the 
respective Grignard reagent as follows [ 121: to a solution of 15 mg of 
PWN in 2 ml dry benzene under NZ was added 0.3 ml of a I M solution 
of the respective Grignard reagent and stirred at room temperature 
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R~~bbit mrile cntlathctlirl erll~ ltrc UWI from # line rrtablirhcd and 
charttstcrincd by flunnttx3iri and cWorker* [I,), Thcw cellt t4rc grown 
in Httm I P-ID mQtlium/ 13% rd !m+n: %r’runl ountnininp epldcrmal 
Browth factor ut It] n@ml in 60 mm pleatic culture tli~hc\ and tire urctl 
ror cxpcrimentt 81 confiucncc, Holridrm pcritnncal mncrophagcc wrrc 
oblttined from fcmttlc Jwixl: aicc by parilaecal lavztgs with icc4alrl 
Dulbcu~o’a PBS. The cells were xuqcndcd in alpha MEM wilh 10% 
fen11 bovine serum and plated in Ilw~ll plartie culture plsrcx (IO’ 
cclls/dixh). Non-adhcrcnt ccllx wcrc rcmovctl after I II by acdiwii cx- 
change and the adherent mnercaphaper cultured uvcrnight prior to MC 
in rxpcririicnrr [3j. 
l.Dt wia~ oxidized in u coll.frcc xystcm in the prcrcncc 0r Cd’ in 
Warn’s F-IO at 37*0. Typically, ‘Wabclcd LDL (Iotl &ml) was in. 
cubated in Ham’s F-10 media containing S i&l cupric sulfate for 24 
h. In cell-induecd niodtfieation al’ LDL, ‘~~l.lal~cletl L13L (IO pg) 
WIIX incubarcd with washed cndothclial cells ia Ham’s F-IO mcdin at 
3756 r0r 24 h p,i II. 
The cx~ent of lipid pcroxidation was mcarurcd as thiobarbituric 
acid-reactive subs~anccs (TDAAS) and cxprcsrcd as malondialdchydc 
cquivalcnts [S,l I]. LDL (50 10 of protein) in 0.S ml was mixed with 
0.3 ml of 6 N hydrachloric acid and 1.5 ml of 0.67% thiobarbituric 
acid in 0.05 N NaQt1. After heating in boiling water for 30 min, the 
samples wcrc ccntrifugcd at 2000 rpm and the optical dcnsiry read at 
532 nm. Fresh tcrrnmcthoxypropaac, which produces malorr- 
dialdehydc, wu used as standard. 
2.8. Agarosc gel eleclrophoresis 
The clcctrophorctic mobility of LDL was mcasurcd in a 0.7Vo gel 
at pM 8,6 in 0.05 M barbital buffer, as reported previously [Ml. LDL 
was identified either by oil Red-0 staining or autoradiography when 
labeled LDL was used. 
2.9. Macrophnge deRradarion of LDL 
The uptake and degradation of “‘I-LDL by mouse peritoneal 
macrophages was measured as the appearance of trichloroacctic acid,, 
soluble radioactivity. This non-iodide radioactivity was formed by ttc 
cells and excreted in the medium following a 5 h incubation of oxidie- 
cd 1251-LDL with the cells [3], 
2.10. Cytotoxicily of spin traps 
The cytotoxicity of the spin trap was determined by microscopic 
observatfon of the endothelial cells as well as by cell protein 
measurements before and after the 24 h incubation period, 
3. RESULTS 
3.1. Effect of F&V on the oxidcrtive modification of 
LDL 
PBN w;1s found to be toxic to the endothelial cells at 
concentrations greater than 5 rnI% At non-toxic con- 
centrations, PUN inhibited the biological modification 
of LBL as determined by the macrophage degradation 
in a dose-depen,dent manner (Fig. 1). Addition of 5 mM 
PBN at the end of the incubation period did not show 
culrrtctl with cultured EC or with Cd * (5 pM) in strum-free H~rn’s 
F-IO media with or without PBN for 24 h, RX indirzttcd. hf~ct the in. 
cubation, the rate nfdcgrrdation of LK31. by macruphagex wns dctcr- 
mined. Values rsprcxnt the nvm 2 SD from 6 cspcrimcnt%. 
any inhibitory effect. This should exclude any non- 
specific effect of PBN on macrophage degradation, 
When LDL was incubated with Cu” * and the cn- 
dothclial cells, thiobarbituric acid-reactive substance 
(TBARS) formation incrcascd (Fig. 2). Although not 
very specific, TBARS measurements have been shown 
to parallel the other oxidative changes (c,g. Ape-B 
degradation, elcctrophoretic mobility, etc.) occurring 
during LDL modification [3]. Oxidation of LDL in the 
presence of PBN inhibits formation of the TBARS to a 
small but significant extent (Fig, 2). It has been 
previously shown that only a small portion of lipid 
hydroperoxides actually decompose into TEARS [ 161. 
This may in part explain the reduced inhibitory effect of 
PBN. 
EC-LOL 
T EC-LOL r 
Fig. 2. Effect of PBN on the generation of TBARS during Cu’ +- and 
EC-induced oxidation of LDL. The incubation conditions are iden- 
tical to that of Fig. 1, except that the medium was analyzed for 
TBARS at the end of the incubation. Values represent the mean k SD 
from 6 experiments. 
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PBN also decreased the clcctrophorctic mobility of 
EC- and (IQ”-modified LBL in a dose-dcpcntlrnt 
manner (Fig. 3). Addrion of PI3N at the end of the in- 
cubation period did not decrease the &?etrophorctic 
mobility, PBN alone did not have any effect on the 
migration of unmodified LBL, Since PBN is not likely 
to react wit\1 rke unsaruraccd aldchydcs (ix, malon- 
dialdehydc, rl-hydroxynonenal, etc.) to an appreciable 
extent, the observed inhibitory effort of PBN may bc 
attributed to its radical scavenging ability. 
PBN ADDUCT 
Fig. 4. The ESP spectra of PBN adduct in the LDL particle (A) and 
in ethanol. Conditions: (A) the incubation mixture contained 6 
mg/ml DLD, 0.5 mM Cuzc , and PBN (100 mM) in a 0.25 ml of PBS 
buffer (pH 7-8, 150 mM). Spectrometer conditions: modulation 
amphtude, 2.0 G; microwave power, 5 mW; scan range, 100 6; time 
constant, 0.25 s. (B) The incubation mixture in (A) was extracted in 
chloroform/methanol (2: I), dried under Nz, and taken up in a 0.2 ml 
of ethanol purged with Nz. Spectrometer conditions: modulation 
amplitude, 0.4 C; microwave power, 5 mW, 
Although the cxnct ~tr~cturc cat” he IJBN-iJ3L radical 
lrdduer still remains to be determined, we feel that this: 
adduct contains a lipid-derived moiety with 14 or more 
carbon atoms baaed on the following observation: of 
the scvcral fatty acid spin labels, only those with 14 or 
more carbon atoms exhibit r9 rotpricdnnlly-immebili%ed 
nitroxide spectrum in the LDL matrix - similar te, that 
of the PBN-LDL. radienl adduct. The PBN-LDL radical 
adduet is, therefore, tcnratively attributed to a primary 
adduct obtained from trappin of a lipid radical. Addi- 
tional mass spcctromctrie analyses are clcsrly ncedetl in 
order ta Fully charseterire this adduct. 
4. DISCUSSION 
The car&protective effects of PBN have previously 
been demonstrated [17-191. PBN has been shown to 
partially rcvcrsc the reperfusion-induced damage in in- 
tact myocardium of dogs [17,18]. This protective 
mechanism has been attributed to the scavenging of 
lipid or lipid-oxy radicals by PBN [ 17,181. PBN has also 
been shown to afford protection against reperfusion- 
induced arrhythmias in isolated heart models [19]. 
Again, radical scavenging by PBN has been proposed to 
account for the observed effects. 
Previous studies have implicated formation of the 
PBN-lipid adduct during lipid peroxidation induced by 
xenobiotics [20-221. However, the structure of this ad- 
duct has not been determined. Using the denterated 
forms of PBN (e.g. PBN-d9 and PBN-did), the PBN- 
lipid adduct has been characterized as a secondary 
PBN-alkyl adduct [23]. This is also consistent with the 
finding that alkyl radicals (e.g. ethyl and pentyl 
radicals) are formed from the fragmentation reactions 
of lipid hydroperoxides [24]. Mowever, the spectral 
parameters of the PBN-LDL-lipid derived adduct (Fig. 
4) reporr.zd in the present study are nor consistent with 
those of b ‘BN-pentyl (CW = ls.OG; &, = 3.70G), PBN- 
decyl (atI = 15.0 G; QH - 3.75 G) and PBN-tetradecyl 
(UN = 1325 G; C4N = 3.95 G) adducts in alcohol. Based 
on this, we conclude that the PBN-LDL-lipid derived 
adduct is not a secondary adduct formed from trapping 
of the alkyd-type radicals by PBN. 
I9 
FEBS LETTERS 
institute about one-half 
t the LDL particle [25]. 
Linoleic acid is pr~ent in more abundance than 
arachidonic acid in the, LDL-particle [25]. One of  the 
major lipid ~rox idat ion products formed during 
Cu ~ + -catalyzed oxidation of  LDL has been determined 
to be the linoleic acid hydroperoxide, and only a small 
portion of  the hydroperoxide has been shown to decom- 






mechanism of inhibition may involve trapl~ing o1' the 
LDL-lipid-derived radical by PBN. 
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